Eukaryotic Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 2 (SPLUNC2)

BPIFA2; PSP; C20orf70; BPI fold-containing family A member 2; Parotid secretory protein

  • Eukaryotic Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 2 (SPLUNC2) Packages (Simulation)
  • Eukaryotic Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 2 (SPLUNC2) Packages (Simulation)
  • Eukaryotic Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 2 (SPLUNC2) Figure. Gene Sequencing (Extract)
  • EPT372Hu61.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Eukaryotic Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 2 (SPLUNC2)

USAGE of the Eukaryotic Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 2 (SPLUNC2)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Eukaryotic Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 2 (SPLUNC2)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Eukaryotic Short Palate, Lung And Nasal Epithelium Carcinoma Associated Protein 2 (SPLUNC2)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GUESTBOOK